Holen Sie sich die Stockscreener-App
23.87
3.59%
-0.89
Handel nachbörslich:
23.86
-0.01
-0.04%
Schlusskurs vom Vortag:
$24.76
Offen:
$24.43
24-Stunden-Volumen:
459.98K
Relative Volume:
0.54
Marktkapitalisierung:
$2.69B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.94%
1M Leistung:
+56.32%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$23.19
$25.40
1-Wochen-Bereich:
$21.10
$26.02
52-Wochen-Spanne:
$12.30
$32.81
Metsera Inc Stock (MTSR) Company Profile
Firmenname
Metsera Inc
Sektor
Branche
Telefon
(212) 784-6595
Adresse
3 WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MTSR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
23.87 | 2.69B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-25 | Eingeleitet | BofA Securities | Buy |
| 2025-02-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-25 | Eingeleitet | Guggenheim | Buy |
Metsera Inc Aktie (MTSR) Neueste Nachrichten
Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR) - Seeking Alpha
Metsera to Present at Bank of America 2025 Global Healthcare Conference - The Manila Times
Metsera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Metsera Rings the Opening Bell - Nasdaq
Metsera Inc’s Market Journey: Closing Weak at 22.74, Down -5.17 - DWinneX
MTSR Shares Experience Surge in Value - knoxdaily.com
Nothing is Better Than Metsera Inc (MTSR) stock at the moment - Sete News
Viking among notable gainers as Pfizer raises deal prospects - MSN
Viking stock rises as Pfizer ups deal prospects (VKTX:NASDAQ) - Seeking Alpha
Metsera Inc. appoints new director and legal officer By Investing.com - Investing.com India
Metsera Inc. appoints new director and legal officer - Investing.com
A Guide To The Risks Of Investing In Metsera Inc (MTSR) - knoxdaily.com
Metric Analysis: Metsera Inc (MTSR)’s Key Ratios in the Limelight - DWinneX
A Closer Look at Metsera Inc (MTSR) Stock Gains - investchronicle.com
Metsera Inc (MTSR) stock analysis: A simple moving average approach - uspostnews.com
Metsera (NASDAQ:MTSR) Shares Gap Up – Time to Buy? - Defense World
Now Is The Time To Build A Position In Metsera Inc (NASDAQ:MTSR) - Marketing Sentinel
Metsera Inc [MTSR] Director makes an insider purchase of 2,222,222 shares worth 40.0 million. - knoxdaily.com
The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com
Taking the lead: Metsera Inc (MTSR) - Sete News
Financial Metrics Exploration: Understanding Metsera Inc (MTSR) Through Ratios - DWinneX
How did Metsera Inc (MTSR) fare last session? - uspostnews.com
Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha
Viking, Structure, Metsera on a tear as Pfizer drops obesity pill - MSN
Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha
Is it possible to buy Metsera Inc(MTSR) shares at a good price now? - uspostnews.com
Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings - insights.citeline.com
Metsera plunges 44% after InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025 - Endpoints News
Metsera sees cash runway into 2027 - TipRanks
Metsera reports Q4 EPS ($3.52) vs. (94c) last year - TipRanks
Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus
Are Metsera Inc’shares a good deal? - US Post News
Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher - marketscreener.com
Metsera Reports Fourth Quarter And Full Year 2024 Financial Results And Continued Portfolio Progress - Marketscreener.com
Form 10-K Metsera, Inc. For: Dec 31 - StreetInsider
Earnings Flash (MTSR) Metsera Posts Q4 Total Operating Expenses $64.5M - Marketscreener.com
Earnings Flash (MTSR) Metsera Posts Q4 Net Loss of $3.52 a Share - MarketScreener
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress - The Manila Times
Metsera Inc (NASDAQ: MTSR) Stock Is Down -21.4% From Its Low: The Uptrend Is Still On - Stocks Register
Amneal Digs Deeper Into GLP-1 Aspirations Following Metsera’s IPO - insights.citeline.com
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On TuesdayDiginex (NASDAQ:DGNX), China Liberal Education (NASDAQ:CLEU) - Benzinga
Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On MondayAlpha Technology Group (NASDAQ:ATGL), American Eagle Outfitters (NYSE:AEO) - Benzinga
Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month - Insider Monkey
Top 10 Insider Purchases Last Month - Insider Monkey
Metsera, Inc. awards full bonuses to executive officers By Investing.com - Investing.com Australia
Metsera, Inc. awards full bonuses to executive officers - Investing.com India
Metsera, Inc. Approves 2024 Executive Cash Bonuses - TipRanks
Finanzdaten der Metsera Inc-Aktie (MTSR)
Es liegen keine Finanzdaten für Metsera Inc (MTSR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):